William R. Ringo

28 years of experience with Eli Lilly and Company where he served on the Operations Committee. He retired as President of Oncology and Critical Care Products. Bill brings a global understanding of the pharmaceutical, biotech, and medical device industry segments as reflected in the number of leadership positions he has held at Lilly. These include Vice President of Sales and Marketing for Cardiac Pacemakers, Inc., a former Lilly subsidiary, and Director of Business Planning for Lilly's Medical Devices and Diagnostics Division and President and GM of Eli Lilly Canada, Inc. in 1988. He returned to Indianapolis in 1991 as Executive Director of Market Research. Subsequently promoted to Vice President, Marketing for U.S. Pharmaceutical Operations in 1993 and Vice President of Sales and Marketing in 1994. Named President of the Infectious Diseases business unit in 1995. Currently serves on the board of a number of early-stage life science companies including Suros Surgical Systems; Praecis Pharmaceutical, Inc., La Jolla Pharmaceuticals; Texas Biotechnology, Inc., Intermunne, Inc., and XCEL. Bill is also a member of the Scientific Board of Advisors for Burrell Ventures. He has a BS degree in Management and MBA degree, both from the University of Dayton, Dayton, Ohio.